The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Share News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LiDCO Chief Executive To Retire Next Year As Half-Year Loss Widens

Tue, 16th Sep 2014 07:34

LONDON (Alliance News) - LiDCO Group PLC Tuesday announced the departure of Chief Executive Terry O'Brien next year, and expressed confidence in achieving profit and revenue growth for its full financial year despite posting a widened loss in the half year to end-July.

O'Brien will retire from the position on his 60th birthday next September. The company said that over the next year O'Brien and the board will seek out a suitable candidate as his successor.

The medical equipment company posted a pretax loss of GBP244,000 in the recent half year, widened from a loss of GBP113,000 in the same period the previous year, as revenue declined to GBP3.7 million from GBP4.2 million.

LiDCO's revenue was hampered by lower sales of disposables and surgery monitors in the UK and Japan, which offset growth from the company's direct sales channel in the US and the rest of the world.

Last year in the UK, the National Health Service provided incentives to drive the purchase of hemodynamic monitors. However these incentives were not repeated in the current year, restricting funding for customers, which hampered LiDCO's performance in the first half. Despite this, LiDCO installed 33 new surgery monitors in the UK, which the company said showed that its installed base of surgical monitors continues to grow.

In Japan, the company said it is reviewing its exclusive distribution arrangements, and is in the process of registering its non-invasive product.

In LiDCO's export markets, excluding Japan, revenues were up 16%, as the company continued to transition from a single exclusive distribution arrangement to a direct sales model in the US. Surgical disposable unit sales in export markets, also excluding Japan, were up 21%.

LiDCO said that whilst is expects a significant portion of its installed base of surgery monitors to be placed, meaning leased, rather than sold, the installed base will continue to drive its growth going forward and increase surgical disposable sales in the second half.

The company expects the pause in the UK market "to be short lived", and said it remains on track to deliver growth in revenues and profitability for the full year.

Shares in LiDCO are untraded Tuesday at 13.25 pence.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2018 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 4 April RenewiTrading statementNext Fifteen Communications GroupFull Year 5 (at

Read more
14 Feb 2017 12:46

LiDCO posts extensive trading update

(ShareCast News) - Cardiovascular monitoring company LiDCO Group provided a trading update for the full year to 31 January on Tuesday, with product revenues in the period expected to be up 14% to £6.76m, with total revenues - including third party products - expected to be up by 8% to £8.21m. The AI

Read more
14 Feb 2017 09:11

LiDCO To Escape Red And Report Small Annual Pretax Profit

Read more
10 Jan 2017 11:50

LiDCO appoints Shane Doorish as head of North America

(ShareCast News) - Hemodynamic monitoring company LiDCO announced the appointment of Shane Doorish as head of North America on Tuesday, with immediate effect. The AIM-traded firm said Doorish was bringing with him 19 years of experience in the healthcare sector having originally trained as a critica

Read more
16 Dec 2016 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Dec 2016 08:07

LiDCO Raises GBP3 Million In Equity To Fund US Expansion Plans (ALLISS)

Read more
11 Oct 2016 11:37

LiDCO narrows loss in first half

(ShareCast News) - Hemodynamic monitoring company LiDCO announced its unaudited interim results for the six months to 31 July on Tuesday, with product revenues up 10% to £3.03m. The AIM-traded firm's total product revenues, including third party products, was up 5% to £3.77m, with US revenues up 37%

Read more
11 Oct 2016 08:27

LiDCO Stems Loss And Pumps Up Exports Of Blood Flow Monitors To US

Read more
11 Aug 2016 09:43

WINNERS & LOSERS SUMMARY: DFS Furniture Is Sitting Comfortably

Read more
25 May 2016 08:03

LiDCO Continues To Expect Year Of Sales Growth And Cash Generation

Read more
18 May 2016 15:05

AGM, EGM Calendar - Week Ahead

Read more
16 May 2016 14:18

Lidco inks US distribution deal with ICU Medical

(ShareCast News) - LiDCO has inked a distribution agreement with partner ICU Medical to sell the LiDCO IM non-invasive hemodynamic monitoring system in the US. LiDCO IM is a specially configured hemodynamic monitor produced exclusively for ICU Medical. It works solely in conjunction with LiDCO's non

Read more
16 May 2016 09:35

WINNERS & LOSERS SUMMARY: Markets Unimpressed By British Land Earnings

Read more
16 May 2016 07:28

LiDCO Signs US Distribution Deal With ICU Medical For IM System

Read more
21 Apr 2016 16:38

LiDCO shows off new hemodynamic monitoring tech

(ShareCast News) - Hemodynamic monitoring company LiDCO was busy in the US capital this week, showing off its new technology LiDCOunity monitor at the 2016 Annual Congress of Advanced Recovery and Perioperative Medicine. The conference is currently being held in Washington, D.C. LiDCO's board said

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.